SMTL ID : 4wtu.1

Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

4 x IOD: IODIDE ION(Non-functional Binders)

IOD.1: 3 residues within 4Å: Chain A: H.64, E.123, S.124 Ligand excluded by PLIP IOD.2: 2 residues within 4Å: Chain A: H.64, K.126 Ligand excluded by PLIP IOD.3: 1 residues within 4Å: Chain A: Y.241 Ligand excluded by PLIP IOD.4: 1 residues within 4Å: Chain A: Q.74 Ligand excluded by PLIP

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 3 residues within 4Å: Chain A: R.69, Y.70, Q.72 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.70, A:Y.70 GOL.6: 10 residues within 4Å: Chain A: K.28, S.29, G.30, Q.31, G.32, Y.33, V.189, R.326, A.354, E.358 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:K.28, A:G.30, A:G.30, A:G.32, A:R.326, A:R.326

1 x 3UT: (5S)-3-(5,6-dihydro-2H-pyran-3-yl)-1-fluoro-7-(2-fluoropyridin-3-yl)spiro[chromeno[2,3-c]pyridine-5,4'-[1,3]oxazol]-2'-amine(Non-covalent)

3UT.7: 19 residues within 4Å: Chain A: G.30, Q.31, G.32, L.49, D.51, G.53, S.54, V.88, Y.90, W.95, F.127, I.129, W.134, I.137, I.145, R.147, Y.217, D.247, G.249 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.49, A:V.88, A:Y.90, A:F.127, A:I.129, A:W.134 Hydrogen bonds: A:D.51, A:Y.217, A:T.250 pi-Stacking: A:Y.90

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheng, Y. et al., An Orally Available BACE1 Inhibitor That Affords Robust CNS A beta Reduction without Cardiovascular Liabilities. Acs Med.Chem.Lett. (2015)

Release Date

2015-03-04

Peptides

Beta-secretase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-secretase 1

Related Entries With Identical Sequence